On September 25th, the first meeting of AMCHAM’s Pharmaceuticals Committee for the year 2023-24 was held in Gurugram (in hybrid fashion) under the chairmanship of Mr. Rakesh Bamzai, Chairman – Pharmaceuticals Committee, AMCHAM and MD & CEO, Mylan Laboratories Ltd. and Ms. Neelima Dwivedi, Co-Chairperson – Pharmaceuticals Committee, AMCHAM and Executive Director, MSD Pharmaceuticals. The meeting was followed by an interactive session with U.S. Embassy officials: Mr. Jonathan Heimer, Honorary National Board Member, AMCHAM and Minister Counselor for Commercial Affairs, Ms. Durra Elmaki, Commercial Officer and Mr. Naveen Rai, Sr. Commercial Specialist (Policy & Government Relations), U.S. Embassy. Industry Experts from Blackstone, Mylan, Johnson & Johnson, Baxter and Deloitte participated. The key activities and initiatives proposed for this year would be a signature event, continued stakeholder engagement and policy advocacy, idea exchange forum and elevating the pharma industry as a key contributor to industry wide policy forums. The committee discussed the idea of a pharma industry CSR event and policy doorknock in India. The committee also discussed creating a whitepaper to focus on policy issues that could be shared with both the Indian and U.S. governments.
By joining AMCHAM India, you become part of an active and dynamic Apex Chamber of U.S. Industry in India with a membership base of more than 400 American companies in India. AMCHAM is an important voice for policy advocacy, a critical source for business intelligence, a vibrant platform for networking and expanding your business.